Lin Elizabeth Yeu 内部人交易：近期 SEC Form 4 交易
过去 18 个月，Lin Elizabeth Yeu（CIK 1842190）在 1 家公司共报告 15 笔 SEC Form 4 内部人交易（最近一笔 2026-09-09）。
| 日期 | 公司 | 身份 | 类型 | 股数 | 市值 |
|---|---|---|---|---|---|
| 2026-09-09 | Tarsus Pharmaceuticals, Inc. (TARS) | Chief Medical Officer | 卖出 | 5,386 | $484,740 |
| 2026-09-09 | Tarsus Pharmaceuticals, Inc. (TARS) | Chief Medical Officer | 卖出 | 1,590 | $135,150 |
| 2026-09-09 | Tarsus Pharmaceuticals, Inc. (TARS) | Chief Medical Officer | 卖出 | 1,590 | $143,100 |
| 2026-09-09 | Tarsus Pharmaceuticals, Inc. (TARS) | Chief Medical Officer | 卖出 | 5,387 | $457,895 |
| 2026-09-03 | Tarsus Pharmaceuticals, Inc. (TARS) | Chief Medical Officer | 卖出 | 4,601 | $339,830 |
| 2026-09-03 | Tarsus Pharmaceuticals, Inc. (TARS) | Chief Medical Officer | 卖出 | 5,387 | $430,960 |
| 2026-09-03 | Tarsus Pharmaceuticals, Inc. (TARS) | Chief Medical Officer | 卖出 | 1,590 | $127,200 |
| 2026-03-19 | Tarsus Pharmaceuticals, Inc. (TARS) | Chief Medical Officer | 卖出 | 379 | $26,041 |
| 2026-03-19 | Tarsus Pharmaceuticals, Inc. (TARS) | Chief Medical Officer | 卖出 | 375 | $26,032 |
| 2026-03-19 | Tarsus Pharmaceuticals, Inc. (TARS) | Chief Medical Officer | 卖出 | 390 | $26,130 |
| 2026-03-17 | Tarsus Pharmaceuticals, Inc. (TARS) | Chief Medical Officer | 买入 | 2,511 | $0 |
| 2025-12-17 | Tarsus Pharmaceuticals, Inc. (TARS) | Chief Medical Officer | 买入 | 6,819 | $0 |
| 2025-12-17 | Tarsus Pharmaceuticals, Inc. (TARS) | Chief Medical Officer | 卖出 | 2,078 | $165,201 |
| 2025-06-17 | Tarsus Pharmaceuticals, Inc. (TARS) | Chief Medical Officer | 买入 | 3,350 | $0 |
| 2025-06-17 | Tarsus Pharmaceuticals, Inc. (TARS) | Chief Medical Officer | 卖出 | 1,006 | $41,326 |
来源：SEC Form 4 申报文件 · 截至 2026-09-09